by Clinical Neuropsychologist | Friday, February 16, 2024 | Neuropsychology (general)
Volume 38, Issue 7, October 2024, Page 1610-1626. If you do not see content above, kindly GO TO SOURCE. Not all publishers encode content in a way that enables republishing at Neuro.vip. This post is Copyright: Michael Brook James Reilly Alexander Korutz Matthew C....
by Clinical Neuropsychologist | Friday, February 16, 2024 | Neuropsychology (general)
Volume 38, Issue 5, July 2024, Page 1256-1271. If you do not see content above, kindly GO TO SOURCE. Not all publishers encode content in a way that enables republishing at Neuro.vip. This post is Copyright: Rachel M. Peters Christine M. Schieszler-Ockrassa Angela...
by Clinical Neuropsychologist | Thursday, February 15, 2024 | Neuropsychology (general)
Neuropsychology, Vol 38(4), May 2024, 309-321; doi:10.1037/neu0000947Objective: Mild cognitive impairment (MCI) is a risk factor for developing Alzheimer’s disease (AD), and about half of older people with MCI will progress to AD within the next 5 years. The aim of...
by Clinical Neuropsychologist | Wednesday, February 14, 2024 | Neuropsychology (general)
Volume 38, Issue 7, October 2024, Page 1647-1666. If you do not see content above, kindly GO TO SOURCE. Not all publishers encode content in a way that enables republishing at Neuro.vip. This post is Copyright: John-Christopher A. Finley Violeta J. Rodriguez Brian M....
by Clinical Neuropsychologist | Thursday, February 8, 2024 | Neuropsychology (general)
Neuropsychology, Vol 38(4), May 2024, 337-346; doi:10.1037/neu0000938Objective: Large research cohorts show robust associations between neuropsychological tests and Alzheimer’s disease (AD) biomarkers, but studies in clinical settings are limited. The increasing...
